Temperature-sensitive liposome-mediated delivery of thrombolytic agents

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Vishal SaxenaBradford J Wood

Abstract

Clinical efficacy of thrombolytic drugs is limited by lack of specific delivery and requires large therapeutic doses which increase toxicity. Encapsulating these drugs in temperature-sensitive liposomes and applying hyperthermia to deliver thrombolytic agents locally to thrombus might theoretically favourably alter the therapeutic window. The objectives of this study were to formulate liposomes encapsulating thrombolytics and assess thrombolytic activity following hyperthermia. Three liposome formulations were investigated: temperature-sensitive liposome (TSL, DPPC:DSPE-PEG2000 (mol% 95:5)), low temperature-sensitive liposome (LTSL, DPPC:MSPC:DSPE-PEG2000 (mol% 85.3:9.7:5)), and traditional temperature-sensitive liposome (TTSL, DPPC:HSPC:Chol:DSPE-PEG2000 (mol% 55:25:15:5)). To characterise temperature-dependent release of high molecular weight cargo from each formulation, fluorescein-conjugated dextrans (70 kDa) were loaded and release was quantified via spectrophotometry. Staphylokinase (SAK), urokinase, and tissue-type plasminogen activator were also loaded individually into each liposome formulation. Leakage at 37 °C and release at 38-44 °C were quantified via chromogenic enzymatic activity assay. Clot lysis was evaluated b...Continue Reading

References

Nov 27, 1999·Ultrasound in Medicine & Biology·V FrenkelY Iger
Dec 22, 1999·Progress in Cardiovascular Diseases·S C Patel, A Mody
Apr 9, 2002·Ultrasound in Medicine & Biology·Kathryn NightingaleGregg Trahey
Dec 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jennifer A ShabbitsLawrence D Mayer
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lars H LindnerMarc Dellian
Sep 14, 2004·Biophysical Journal·J K ArmstrongT C Fisher
Jan 5, 2005·Thrombosis and Haemostasis·Anirban Sen GuptaRoger E Marchant
Aug 5, 2006·Thrombosis Research·Susan D Tiukinhoy-LaingDavid D McPherson
Mar 17, 2007·Journal of Drug Targeting·Susan D Tiukinhoy-LaingMelvin E Klegerman
Jun 15, 2007·Journal of the American College of Cardiology·Konstantinos ToutouzasChristodoulos Stefanadis
Nov 21, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lars H LindnerRolf D Issels
Nov 23, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·A Cohen
Jun 24, 2008·Journal of Liposome Research·Melvin E KlegermanDavid D McPherson
Nov 4, 2008·Expert Opinion on Drug Delivery·Tamer A Elbayoumi, Vladimir P Torchilin
Feb 17, 2009·Thrombosis Research·George J ShawChristy K Holland
Jun 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·David PetersErkki Ruoslahti
Jul 30, 2009·Protein Expression and Purification·Bhaskarjyoti PrasadSriram Padmanabhan
Jan 16, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Li LiGerben A Koning
Feb 24, 2010·Journal of Internal Medicine·A V Alexandrov
Oct 4, 2011·International Journal of Pharmaceutics·Xin ZhangXiao Yun Xu
Jul 5, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Martin HossannLars H Lindner
Jan 8, 2013·Expert Opinion on Drug Delivery·Jonathan P May, Shyh-Dar Li
Feb 2, 2013·Expert Review of Neurotherapeutics·H Steven Block, José Biller
Jun 19, 2014·JAMA : the Journal of the American Medical Association·Saurav ChatterjeeJay Giri

❮ Previous
Next ❯

Citations

Feb 16, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Stepan KoudelkaJaroslav Turánek
Oct 26, 2016·Journal of Thrombosis and Thrombolysis·Hassan BardaniaMehrdad Faizi
Oct 30, 2016·Bioengineered· Adivitiya, Yogender Pal Khasa
Jul 22, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Sergio CurtoPunit Prakash
Sep 26, 2017·Therapeutic Delivery·Lalit KumarBhuvaneshwar Vaidya
Aug 14, 2020·Small·Soodabeh HassanpourAli Khademhosseini
Aug 22, 2017·Advanced Functional Materials·Haoyuan Huang, Jonathan F Lovell
Aug 2, 2017·BioMed Research International·Anna Tanka-SalamonKrasimir Kolev
Feb 19, 2021·Journal of Stroke·Dmitri NikitinDong-Eog Kim
Sep 9, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maximilian RegenoldChristine Allen
Jul 20, 2019·Brain Research Bulletin·Gisele E BruchAndré R Massensini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.